Tango Therapeutics to Participate in Upcoming Investor Conferences

February 2, 2023

https://www.globenewswire.com/news-release/2023/02/02/2600305/0/en/Tango-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

BOSTON, Feb. 02, 2023 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ:TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in the following upcoming investor conferences in February.

Read more at globenewswire.com

Related news for (TNGX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.